Stuart Laermer
Corporate Officer/Principal chez Fisher Scientific Canada
Profil
Stuart Laermer is currently the Director of Biotechnology & Specialty Products at Fisher Scientific Canada.
Previously, he worked as the Director of Business Development at Hoffmann-La Roche, Inc., Vice President of Business Development at Synthon Chiragenics Corp., and Chief Business Officer at Oxurion NV.
Mr. Laermer has a graduate degree from The Trustees of Columbia University in The City of New York and an MBA from New York University.
Postes actifs de Stuart Laermer
| Sociétés | Poste | Début |
|---|---|---|
| Fisher Scientific Canada | Corporate Officer/Principal | 19/08/2010 |
Anciens postes connus de Stuart Laermer
| Sociétés | Poste | Fin |
|---|---|---|
| OXURION NV | Corporate Officer/Principal | 01/01/2013 |
Synthon Chiragenics Corp.
 Synthon Chiragenics Corp. Pharmaceuticals: MajorHealth Technology Synthon Chiragenics Corp. researches and develops carbohydrate-based pharmaceuticals. The company is headquartered in Monmouth Junction, NJ. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur/Membre du Conseil | 07/01/2011 |
Formation de Stuart Laermer
| New York University | Masters Business Admin |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OXURION NV | Health Technology |
| Entreprise privées | 3 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Fisher Scientific Canada | |
Synthon Chiragenics Corp.
Synthon Chiragenics Corp. Pharmaceuticals: MajorHealth Technology Synthon Chiragenics Corp. researches and develops carbohydrate-based pharmaceuticals. The company is headquartered in Monmouth Junction, NJ. | Health Technology |
